Importance of Competency level and its assessment in Pharmaceutical Industry

Muddukrishna, BS; T, Vamshi Krishna; Kumar, Lalit; K, Girish Pai

doi:10.5958/0974-360x.2018.00027.6

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…indicated that training and competency levels play a key role in ensuring the effectiveness of medical staff in pharmaceutical industries. [ 37 ] According to Muddukrishna et al ., training and development are complimentary and parallel to competency levels in the pharmaceutical industries. [ 37 ] All participants in this study said that training and development programs help employees to be more determined to apply learned knowledge and skills in daily practice.…”

Section: Resultsmentioning

confidence: 99%

“…[ 37 ] According to Muddukrishna et al ., training and development are complimentary and parallel to competency levels in the pharmaceutical industries. [ 37 ] All participants in this study said that training and development programs help employees to be more determined to apply learned knowledge and skills in daily practice. Part of the knowledge obtained in the interviews included the importance of conducting ethical training in the workplace.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Marketing training strategies that pharmaceutical sales managers use to reduce unethical behavior

Sawad

Andrews

2022

J Edu Health Promot

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Marketing training strategies that pharmaceutical sales managers use to reduce unethical behavior

Sawad

Andrews

2022

J Edu Health Promot

View full text Add to dashboard Cite

A Retrospective Study of Warning letters Issued by US FDA Over 2019-2021

Jinja

Vyas

Patel

et al. 2022

AJPR

View full text Add to dashboard Cite

The United States Food and Drug Administration (US FDA) is a department of health and human services federal agency. If the FDA notices major violations of federal regulations, it sends warning letters to pharmaceutical makers, distributors, and clinical investigators. The nature of the infractions discovered, as well as the FDA's proposed corrective activities, are detailed in these warning letters. Following the completion of the corrective activities, the recipient may request a follow-up inspection. This review article examines the current state of warning letters issued by the US Food and Drug Administration (FDA) from 2019 to 2021. The main goal of this study is to examine warning letters related to drug and determine what the significant violations.

show abstract

Importance of Competency level and its assessment in Pharmaceutical Industry

Cited by 2 publications

References 0 publications

Marketing training strategies that pharmaceutical sales managers use to reduce unethical behavior

Marketing training strategies that pharmaceutical sales managers use to reduce unethical behavior

A Retrospective Study of Warning letters Issued by US FDA Over 2019-2021

Contact Info

Product

Resources

About